MedTrace Logo

COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020

NCT04723290 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2817

Last updated 2021-03-25

No results posted yet for this study

Summary

The management of the Grand Hôpital de Charleroi hospital authorized the performance of a serology for each member of the establishment's staff in order to better characterize the proportion of its employees who have already been in contact with the SARS CoV-2 virus for organizational and evaluation purposes symptoms.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Serological tests for SARS Cov-2

Each participant will have a blood test on a dry tube of maximum 8 ml of whole blood

Sponsors & Collaborators

  • Grand Hôpital de Charleroi

    lead OTHER

Principal Investigators

  • Nathalie de Visscher, MD · Grand Hôpital de Charleroi

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-20
Primary Completion
2020-10-31
Completion
2020-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04723290 on ClinicalTrials.gov